Patterns of Psychotherapeutic Drug Use Among Adults in San Francisco

Mellinger, Glen D.

doi:10.1001/archpsyc.1971.01750170001001

Cited by 102 publications

(22 citation statements)

References 9 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The higher prevalence of any psychotropic medication use and ASH and antidepressant use among women compared with men has been reported in several other studies [30][31][32][33][34] and may be explained by significant gender differences in the prevalence of psychological symptoms/ disorders [35][36][37], treatment-seeking behavior [38], and physician prescribing behavior [39,40]. The higher prevalence of psychotropic medication use among older adults, which is also well documented [31][32][33]41], also may be explained by the higher prevalence of anxiety, depression, and insomnia among this age group [36].…”

Section: Demographic Subgroups and Psychotropic Drug Usesupporting

confidence: 64%

“…More than half of all antidepressant users reported using a tricyclic agent (see Table 2) (58%, 95% CI 51-65) and 28% a selective-serotonin-reuptake inhibitor (SSRI) (95% CI [21][22][23][24][25][26][27][28][29][30][31][32][33][34][35]. The number of persons reporting monoamine oxidase inhibitor use was too small to provide a statistically reliable national estimate.…”

Section: Psychotropic Medication Use and Duration Of Use By Drug Classmentioning

confidence: 99%

See 1 more Smart Citation

Prescription psychotropic medication use among the U.S. adult population: results from the third National Health and Nutrition Examination Survey, 1988–1994

Paulose-Ram

Jonas

Orwig

et al. 2004

Journal of Clinical Epidemiology

View full text Add to dashboard Cite

Section: Demographic Subgroups and Psychotropic Drug Usesupporting

confidence: 64%

Section: Psychotropic Medication Use and Duration Of Use By Drug Classmentioning

confidence: 99%

Prescription psychotropic medication use among the U.S. adult population: results from the third National Health and Nutrition Examination Survey, 1988–1994

Paulose-Ram

Jonas

Orwig

et al. 2004

Journal of Clinical Epidemiology

View full text Add to dashboard Cite

“…The use of psychotropic drugs in the general popula tion has been increasing steadily over the last 20 years, to the point that there is now some alarm that their usage may no longer be restricted to proper therapeutic indica tions [Cooperstock and Sims, 1971;Mellinger et al" 1971]. Amongst the various factors involved in the use of psychotropic drugs, sociodemographic variables seem to play a particularly important role.…”

Section: Introductionmentioning

confidence: 99%

Use of Psychotropic Drugs in General Medical Geriatric Inpatients

Magni

Schifano

M³

et al. 1986

Neuropsychobiology

View full text Add to dashboard Cite

The authors have evaluated the psychotropic drug use patterns and psychological distress (with the Symptom Distress Checklist, SCL-90) amongst 331 elderly medical inpatients. Forty-two percent of the sample took psychotropic drugs during their hospitalization period. The drugs most commonly used were anxiolytics and hypnotics of the benzodiazepine class. Subjects to whom psychotropic drugs were prescribed reported higher psychological distress compared to those not receiving them; however, a score of moderate distress in the depression and sleep disturbances subscales was reported by a relatively high percentage of subjects not receiving psychotropics. Patients taking antidepressants reported scores of psychological suffering higher than those under benzodiazepine treatment: such a difference not only related to the depression subscale, but to the majority of the symptom areas investigated by the SCL-90.

show abstract

“…It is most extensively em ployed in family practice since 60 % of all prescriptions for psychotropic me dications are written by family practitioners (19). This finding, however, is qualified by the different expectations attached to treatment entry in these three settings.…”

Section: Treatment Selectionmentioning

confidence: 99%

Entry and Exit from Treatment: Some Consequences of Pretreatment Experience for Treatment Response

Pt¹,

Rickels²,

En³

1973

Int Pharmacopsychiatry

View full text Add to dashboard Cite

Pretreatment events can be combined with events during treatment to describe a single treatment process having five stages: (a) the symptom experience stage, (b) the stage of sick role assumption, (c) the medical care contact stage, (d) the dependent patient role stage, and (e) the recovery or rehabilitation stage. The influence an early stage of this process can exert on a subsequent one is illustrated by a comparison of treatment outcomes for similar kinds of psychoneurotic patients receiving pharmacotherapy in different settings. Present evidence suggests that favorable response to minor tranquilizers is more likely in family practice than in private psychiatric practice or hospital clinics. Thus, the selection of treatment setting, an important event prior to the dispensing of medical care, is shown to have implications for the outcome of treatment. Further research to qualify this conclusion is proposed.

show abstract

Patterns of Psychotherapeutic Drug Use Among Adults in San Francisco

Cited by 102 publications

References 9 publications

Prescription psychotropic medication use among the U.S. adult population: results from the third National Health and Nutrition Examination Survey, 1988–1994

Prescription psychotropic medication use among the U.S. adult population: results from the third National Health and Nutrition Examination Survey, 1988–1994

Use of Psychotropic Drugs in General Medical Geriatric Inpatients

Entry and Exit from Treatment: Some Consequences of Pretreatment Experience for Treatment Response

Contact Info

Product

Resources

About